Cotton Pellet Granuloma

  • Principle
  • Experimental Materials
  • Experimental Procedure

Materials Required

/

Principle

Cotton pellet granuloma is a classical in vivo chronic inflammation model used to evaluate the anti-inflammatory potential of test substances by measuring their ability to inhibit granuloma tissue formation around an implanted foreign body (cotton pellet) in rodents. The method is based on the biological response to a sterile implanted material, which induces proliferative phase inflammation characterized by fibroblast proliferation and collagen-rich granuloma formation, and the final readout reflects the extent of chronic inflammatory tissue growth surrounding the pellet. In multiple preclinical pharmacological evaluations, inhibition of cotton pellet-induced granuloma formation has been used as an indicator of anti-inflammatory activity in both synthetic and natural product screening contexts.

MCE has not independently verified the accuracy of these methods. They are for reference only.

Experimental Materials

• Sterile cotton pellets: used as a foreign body implant to induce granuloma formation in vivo.

• Test compounds (plant extracts or synthetic drugs): administered to evaluate anti-inflammatory efficacy in chronic inflammation models.

• Surgical instruments for implantation and excision of cotton pellets: used for in vivo implantation and retrieval of granuloma tissue.

• Analytical balance: used for measurement of granuloma tissue formation by weight assessment of excised pellets.

Experimental Procedure

• Rodent models (commonly rats in pharmacological screening studies) are prepared for implantation of sterile cotton pellets, which serve as the inflammatory stimulus for chronic granuloma formation.

• Test compounds are prepared according to experimental design in studies evaluating anti-inflammatory activity in vivo using cotton pellet granuloma models.

• Sterile cotton pellets are implanted into experimental animals as a foreign body to induce granuloma formation as part of a chronic inflammation model used in anti-inflammatory drug screening.

• Following implantation, animals are maintained under experimental conditions to allow development of granulomatous tissue around the pellet, reflecting chronic inflammatory progression.

• After the experimental period, cotton pellets with surrounding granulomatous tissue are removed and used to assess the extent of inflammation.

• The primary endpoint is the extent of granuloma formation, commonly assessed by measuring the weight of the dried cotton pellet with attached granulomatous tissue, which reflects the degree of chronic inflammatory response.

• Reduction in granuloma mass in treated groups compared with control groups is interpreted as evidence of anti-inflammatory activity in chronic inflammation models.

Share